NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Right, and as you say “not fully commercial” makes sense. That’s why I suggested the “conditional approval” as a potential option. One of the other other issues the MHRA would have for approval based on manual production is supply vs demand. If Advent can only produce 40 - 45 treatments per month manually, why create a large demand that couldn’t be fulfilled until automated manufacturing is ready? All that is needed right now is the funding to provide the treatment to patients that will match the current supply capability.